Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U0KJ
|
|||
Former ID |
DNC011424
|
|||
Drug Name |
MRS-2160
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H13ClN3O8P
|
|||
Canonical SMILES |
CC1=C(C(=C(C(=N1)N=NC2=CC(=C(C=C2)C(=O)O)Cl)COP(=O)(O)O)C=O)O
|
|||
InChI |
1S/C15H13ClN3O8P/c1-7-13(21)10(5-20)11(6-27-28(24,25)26)14(17-7)19-18-8-2-3-9(15(22)23)12(16)4-8/h2-5,21H,6H2,1H3,(H,22,23)(H2,24,25,26)
|
|||
InChIKey |
KMRWDYZPXRUNAQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | P2X purinoceptor 4 (P2RX4) | Target Info | Inhibitor | [1] |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction |
References | Top | |||
---|---|---|---|---|
REF 1 | Purine and pyrimidine (P2) receptors as drug targets. J Med Chem. 2002 Sep 12;45(19):4057-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.